BioHealth News
BISNOW: ‘Signs Of Rebound’ Emerging In Biotech, $11B In VC Funds To Kick-Start Recovery, Alexandria Says
April 23, 2024, Patrick Sisson, Bisnow National - One of the life sciences real estate’s biggest players sees a clear road to recovery, predicting…
Read More
AMPEL BioSolutions Selected as Member of Prestigious Federal Health Innovation ARPA-H Network
CHARLOTTESVILLE, VA – April 22, 2024 – AMPEL BioSolutions has been selected as a member - or "spoke" - of the Customer Experience Hub of ARPANET-H, a prestigious nationwide health innovation…
Read More
USP joins BARDA’s BioMaP-Consortium
Rockville, MD, April 22, 2024 – U.S. Pharmacopeia (USP) is honored to announce its selection as a member of the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium),…
Read More
Gaithersburg’s Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update
Shenzhen Salubris commits additional funding to continue research and development of novel, complex biologics First patient enrolled in RENEU-HF, the Phase 2 clinical trial…
Read More
Rockville’s DrFirst Acquires Myndshft Technologies to Revolutionize Medication Management by Addressing Both Pharmacy and Medical Benefits
Pioneering Move Unites Medical and Pharmacy Benefits, Enhancing Access, Affordability, and Adherence for Specialty Medications and Procedures ROCKVILLE, Md., April 18, 2024 /PRNewswire/ -- Healthcare technology pioneer DrFirst today…
Read More
Novavax to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom
April 18, 2024For Global Investor Audience Only Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across…
Read More
Novel cell therapy treatments offer promise to immune-compromised children
Multi-institute clinical trial demonstrates therapy can be safely used in pediatric regional centers WASHINGTON, April 18, 2024 (GLOBE NEWSWIRE) -- In a first-of-its-kind clinical…
Read More
Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections
OXFORD, United Kingdom, April 18, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, a clinical-stage biopharmaceutical company developing novel T…
Read More
I95Business: CarrTech’s Sue Carr Invents and Innovates in BioHealth
By Rebekka Spiller - For inventor and CEO Sue Carr, tenacity and determination drive success. The founder of CarrTech Corp. says that challenges helped her…
Read More
TIME: We Need to be Ready for Biotech’s ChatGPT Moment
BY ERIC SCHMIDTAPRIL 16, 2024 4:20 PM EDTSchmidt, Commissioner, National Security Commission on Emerging Biotechnology; Co-founder with his wife Wendy, Schmidt Sciences; Former CEO…
Read More
BioPharmaDive: Biotech landlord (and BHI Board Member) Joel Marcus on research clusters and the sector’s recovery
Joel Marcus, the longtime head of Alexandria Real Estate Equities, sees few near-term challengers to the established biotech hubs of Boston, San Diego and…
Read More
FDA establishes CDER Center for Clinical Trial Innovation (C3TI)
[4/15/2024] Today, FDA's Center for Drug Evaluation and Research (CDER) announced the launch of the CDER Center for Clinical Trial Innovation (C3TI). C3TI’s mission is to promote…
Read More
Pitchbook: 3 charts: The US has more startups than VCs can support
2024 may well become the year of the bootstrapped founder. The startup “mass extinction event” that doomsayers have predicted for two years is likely…
Read More
Adventist HealthCare Earns Spot on Newsweek’s Most Trustworthy Companies in America 2024 List
GAITHERSBURG, Md. – Adventist HealthCare has been named one of Newsweek’s Most Trustworthy Companies in America 2024. The list of 700 U.S. companies was announced…
Read More
STAT: NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain
SAN DIEGO — Kimryn Rathmell, director of the National Cancer Institute, gestured toward the screen and asked an audience of clinicians, researchers, and patient…
Read More